European Medicines Agency - Regulatory - Regulation of medicines

D - Description



  Description

Name

ECFS-CTN - European Cystic Fibrosis Society - Clinical Trials Network

Year of foundation 2008
Preterm and/or term newborn Yes
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network newborn to 17 years
Multispeciality? Specify No
Speciality/disease specific? Specify Disease specific: Cystic Fibrosis
Conditions covered? Specify Cystic Fibrosis
Procedure/Intervention specific? Specify No, we cover all interventions as well as observational studies.
Number of collaborating countries 17.
List of collaborating countries Our current collaborating countries are: Austria, Belgium, Czech Republic, Denmark, Germany, France, Hungary, Ireland, Israel, Italy, Poland, Portugal, Spain, Sweden, Switzerland, The Netherlands, UK
Number of collaborating centres 54
List of collaborating centres http://www.ecfs.eu/ctn/list-ctn-centres
Type of activity/studies
Clinical Studies Yes
Experimental research Yes
Other activity • Site Training • Standardization of procedures (outcome parameters) • Central reading hubs for certain outcome measures • Protocol review • Networking for investigators and research coordinators • Informing & educating people with CF about clinical trials • Developing patient-reported outcome tool • Encourage, support & facilitate investigator-initiated trials • Participate in European projects (e.g. HIT-CF Europe, ERN Lung), and collaborations to improve clinical trials (e.g. Enpr-EMA, Conect4Children, Coalition for Reducing Bureaucracy In Clinical Trials)